Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

While praiseworthy, a Centers for Medicare & Medicaid Services (CMS) decision to halt payment on additional costs generated by certain infections should have gone further and included methicillin-resistant Staphylococcus aureus (MRSA), a consumer advocacy group argues.

Consumers, hospital critics welcome CMS changes